Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Morgan J Homan"'
Autor:
Catherine Christen, Morgan J Homan, Victoria R Nachar, Shawna Kraft, Justin H Reid, Lydia L. Benitez, Anna Brown, Shannon Hough, Rachel L McDevitt, David Frame
Publikováno v:
Supportive Care in Cancer. 29:6505-6510
Nausea, vomiting, constipation, and diarrhea are common cancer and cancer therapy adverse effects. Pharmacists are uniquely positioned to optimize patient symptom control and minimize excess use of hospital resources, such as emergency department vis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8380f4f3aef4ceba9ebd4ae8a5d3506
https://doi.org/10.1007/s00520-021-06239-0
https://doi.org/10.1007/s00520-021-06239-0
Autor:
Manjunath P. Pai, Karthik Ravi, Holly Roberts, Miao He, Lydia L. Benitez, Dale L. Bixby, Andrea Franson, Bernard L. Marini, Morgan J Homan, Zachary Miklja, Carl Koschmann, Bo Wen, Anthony J. Perissinotti
Publikováno v:
Leuk Lymphoma
The use of tyrosine kinase inhibitors (TKIs) targeting the BCR-ABL fusion protein have dramatically changed the clinical management and outcomes for patients with chronic myelogenous leukemia (CML)...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9752874d2ae80e2e93169e5c9c3ae32c
https://doi.org/10.1080/10428194.2021.1894647
https://doi.org/10.1080/10428194.2021.1894647
Autor:
Morgan J Homan, Holly Roberts, Aleksas Matvekas, Manjunath P. Pai, Carl Koschmann, Bernard L. Marini, Andrea Franson, Karthik Ravi, Cai Liu, Miao He
Publikováno v:
Cancer Chemother Pharmacol
PURPOSE: Panobinostat, an orally bioavailable pan-HDAC inhibitor, has demonstrated potent activity in multiple malignancies, including pediatric brain tumors such as DIPG, with increased activity against H3K27M mutant cell lines. Given limited eviden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a4829cc94df0c692c462a79c7daa30f
https://europepmc.org/articles/PMC8896403/
https://europepmc.org/articles/PMC8896403/
Autor:
Morgan J, Homan, Justin H, Reid, Victoria R, Nachar, Lydia L, Benitez, Anna M, Brown, Shawna, Kraft, Shannon, Hough, Catherine, Christen, David, Frame, Rachel L, McDevitt
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(11)
Nausea, vomiting, constipation, and diarrhea are common cancer and cancer therapy adverse effects. Pharmacists are uniquely positioned to optimize patient symptom control and minimize excess use of hospital resources, such as emergency department vis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fec48848d0855a600f6a4837a4c647a1
https://pubmed.ncbi.nlm.nih.gov/33905012
https://pubmed.ncbi.nlm.nih.gov/33905012
Autor:
Micah K Harris, Evan Cantor, Amy K. Bruzek, Bernard L. Marini, Carl Koschmann, Morgan J Homan, Andrea Franson, Abed Rahman Kawakibi, Ramya Ravindran, Viveka Nand Yadav, Kyle Wierzbicki, Karthik Ravi, Rodrigo Teodoro
Publikováno v:
Current Oncology Reports. 22
The original version of this review article unfortunately contained a mistake in the author group section.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b633a13d277b9a9a923af289cb13c0e4
https://doi.org/10.1007/s11912-020-00912-z
https://doi.org/10.1007/s11912-020-00912-z
Autor:
Bernard L. Marini, Amy K. Bruzek, Kyle Wierzbicki, Carl Koschmann, Andrea Franson, Rodrigo Teodoro, Ramya Ravindran, Karthik Ravi, Evan Cantor, Morgan J Homan, Abed Rahman Kawakibi, Micah K Harris, Viveka Nand Yadav
Publikováno v:
Curr Oncol Rep
PURPOSE OF REVIEW: H3K27M is a frequent histone mutation within diffuse midline gliomas and is associated with a dismal prognosis, so much so that the 2016 CNS WHO classification system created a specific category of “Diffuse Midline Glioma, H3K27M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b2fb58f150e39ae7da3df6d0b3bd3c3
https://doi.org/10.1007/s11912-020-0877-0
https://doi.org/10.1007/s11912-020-0877-0
Autor:
Morgan J Homan, Anthony J. Perissinotti, Bernard L. Marini, Lydia L. Benitez, Kristen Pettit, Patrick W. Burke, Devon Stonerock, Dale L. Bixby
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S210
Context Secondary AML (sAML) represents up to 30% of total AML cases and is associated with a poor porgnosis. Response rates to traditional chemotherapy regimens are poor. Prior studies have shown that both fludarabine, high-dose cytarabine, and gran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fad79bca33690b049dfff37e65760e4
https://doi.org/10.1016/s2152-2650(20)30771-0
https://doi.org/10.1016/s2152-2650(20)30771-0
Autor:
Govind Warrier, Sarah Yentz, Morgan J Homan, Shawna Kraft, Christopher D. Lao, Leslie A. Fecher
Publikováno v:
Journal of Clinical Oncology. 38:e22086-e22086
e22086 Background: Patients with stage III melanoma are at high risk for recurrence after resection of the primary lesion. The Combi-AD study showed adjuvant therapy with BRAF inhibitor, dabrafenib (D), and MEK inhibitor, trametinib (T), in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::beadd8eeb930c31d59f7098d3d942563
https://doi.org/10.1200/jco.2020.38.15_suppl.e22086
https://doi.org/10.1200/jco.2020.38.15_suppl.e22086